Oxford University extends COVID-19 vaccine study to children, some as young as 6

📆 2/13/2021 11:45 PM
📰 YahooNews

⏱ Reading Time:
12 sec. here
2 min. at publisher
📊 Quality Score:
News: 8%
Publisher: 59%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

Oxford University is extending its COVID-19 vaccine study to include children -- some as young as 6. Together with three partner sites in London, Southampton and Bristol, Oxford will launch the first study to learn how children and young adults (ages 6 to 17) respond to the ChAdOx1 nCoV-19 coronavirus vaccine. Previous trials of the vaccine have shown that it is safe, but this phase 2 trial -- funded by the National Institute for Health Research (NIHR) and AstraZeneca -- will show if kids have a good immune response to the shot.

Previous trials of the vaccine have shown that it is safe, but this phase 2 trial -- funded by the National Institute for Health Research and AstraZeneca -- will show if kids have a good immune response to the shot.

PHOTO: The AstraZeneca COVID-19 vaccine is ready to be used at a homeless shelter in Romford, east London, Feb. 3, 2021. In a study by Oxford University, the AstraZeneca vaccine has been shown to reduce transmission of the virus.

Write Comment

But why tho

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

Law Law Latest News, Law Law Headlines